You are here

  • Home
  • Archive
  • Volume 11, Issue 9
  • Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events

Article info

Article menu
Clinical/translational cancer immunotherapy
Original research
Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events

Authors

  • Karolina Gente Department of Internal Medicine V - Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Leonore Diekmann Department of Internal Medicine V - Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Lea Daniello Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases (NCT) at University Hospital Heidelberg, Heidelberg, GermanyTranslational Lung Research Center Heidelberg (TLRC-H), Member of German Center for Lung Research, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Julia Will Department of Internal Medicine V - Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Manuel Feisst Institute of Medical Biometry (IMBI), University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Victor Olsavszky Department of Dermatology, University Medical Centre Mannheim, Mannheim, Germany PubMed articlesGoogle scholar articles
  • Janine Günther Department of Internal Medicine V - Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Hanns-Martin Lorenz Department of Internal Medicine V - Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • M Margarida Souto-Carneiro Department of Internal Medicine V - Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Jessica C Hassel Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Petros Christopoulos Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases (NCT) at University Hospital Heidelberg, Heidelberg, GermanyTranslational Lung Research Center Heidelberg (TLRC-H), Member of German Center for Lung Research, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Jan Leipe Department of Medicine V - Division of Rheumatology, University Medical Centre Mannheim, Mannheim, Germany PubMed articlesGoogle scholar articles

Citation

Gente K, Diekmann L, Daniello L, et al
Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events
Journal for ImmunoTherapy of Cancer 2023;11:e007557. doi: 10.1136/jitc-2023-007557
Online issue publication 
December 25, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.